Risks of Adverse Outcomes for Hospitalized COVID-19 Patients during the Four Waves in Brazil According to SARS-CoV-2 Variants, Age Group, and Vaccine Status

Brazil was hit with four consecutive waves of COVID-19 until 2022 due to the ancestral SARS-CoV-2 (B.1 lineage), followed by the emergence of variants/subvariants. Relative risks of adverse outcomes for COVID-19 patients hospitalized during the four waves were evaluated. Data were extracted from the...

Full description

Bibliographic Details
Main Authors: Natália Satchiko Hojo-Souza, Waasila Jassat, Daniel Ludovico Guidoni, Fernanda Sumika Hojo de Souza
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/15/10/1997
_version_ 1797572073780936704
author Natália Satchiko Hojo-Souza
Waasila Jassat
Daniel Ludovico Guidoni
Fernanda Sumika Hojo de Souza
author_facet Natália Satchiko Hojo-Souza
Waasila Jassat
Daniel Ludovico Guidoni
Fernanda Sumika Hojo de Souza
author_sort Natália Satchiko Hojo-Souza
collection DOAJ
description Brazil was hit with four consecutive waves of COVID-19 until 2022 due to the ancestral SARS-CoV-2 (B.1 lineage), followed by the emergence of variants/subvariants. Relative risks of adverse outcomes for COVID-19 patients hospitalized during the four waves were evaluated. Data were extracted from the largest Brazilian database (SIVEP-Gripe), and COVID-19 patients who were hospitalized during the peak of each of the four waves (15-week intervals) were included in this study. The outcomes of in-hospital death, invasive (IMV) and non-invasive (NIV) ventilation requirements, and intensive care unit (ICU) admission were analyzed to estimate the relative risks. A higher risk of in-hospital death was found during the second wave for all age groups, but a significant reduction was observed in the risk of death for the elderly during the third and fourth waves compared to patients in the first wave. There was an increased risk of IMV requirement and ICU admissions during the second wave for patients aged 18–59 years old compared to the first wave. Relative risk analysis showed that booster-vaccinated individuals have lower risks of in-hospital death and IMV requirement in all age groups compared to unvaccinated/partially vaccinated patients, demonstrating the relevance of full/booster vaccination in reducing adverse outcomes for patients who were hospitalized during the variant prevalence.
first_indexed 2024-03-10T20:49:38Z
format Article
id doaj.art-2b999cf92fde4efda6f65de7a1030c41
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T20:49:38Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-2b999cf92fde4efda6f65de7a1030c412023-11-19T18:26:39ZengMDPI AGViruses1999-49152023-09-011510199710.3390/v15101997Risks of Adverse Outcomes for Hospitalized COVID-19 Patients during the Four Waves in Brazil According to SARS-CoV-2 Variants, Age Group, and Vaccine StatusNatália Satchiko Hojo-Souza0Waasila Jassat1Daniel Ludovico Guidoni2Fernanda Sumika Hojo de Souza3Laboratory of Immunopathology, Oswaldo Cruz Foundation—Minas, Av. Augusto de Lima, 1715, Belo Horizonte 30190-002, MG, BrazilDivision of Public Health Surveillance and Response, National Institute for Communicable Diseases, Johannesburg 2131, South AfricaDepartment of Computing, Federal University of Ouro Preto, Morro do Cruzeiro Campus, Ouro Preto 35400-000, MG, BrazilDepartment of Computing, Federal University of Ouro Preto, Morro do Cruzeiro Campus, Ouro Preto 35400-000, MG, BrazilBrazil was hit with four consecutive waves of COVID-19 until 2022 due to the ancestral SARS-CoV-2 (B.1 lineage), followed by the emergence of variants/subvariants. Relative risks of adverse outcomes for COVID-19 patients hospitalized during the four waves were evaluated. Data were extracted from the largest Brazilian database (SIVEP-Gripe), and COVID-19 patients who were hospitalized during the peak of each of the four waves (15-week intervals) were included in this study. The outcomes of in-hospital death, invasive (IMV) and non-invasive (NIV) ventilation requirements, and intensive care unit (ICU) admission were analyzed to estimate the relative risks. A higher risk of in-hospital death was found during the second wave for all age groups, but a significant reduction was observed in the risk of death for the elderly during the third and fourth waves compared to patients in the first wave. There was an increased risk of IMV requirement and ICU admissions during the second wave for patients aged 18–59 years old compared to the first wave. Relative risk analysis showed that booster-vaccinated individuals have lower risks of in-hospital death and IMV requirement in all age groups compared to unvaccinated/partially vaccinated patients, demonstrating the relevance of full/booster vaccination in reducing adverse outcomes for patients who were hospitalized during the variant prevalence.https://www.mdpi.com/1999-4915/15/10/1997COVID-19SARS-CoV-2variants of concernwavesadverse outcomesBrazil
spellingShingle Natália Satchiko Hojo-Souza
Waasila Jassat
Daniel Ludovico Guidoni
Fernanda Sumika Hojo de Souza
Risks of Adverse Outcomes for Hospitalized COVID-19 Patients during the Four Waves in Brazil According to SARS-CoV-2 Variants, Age Group, and Vaccine Status
Viruses
COVID-19
SARS-CoV-2
variants of concern
waves
adverse outcomes
Brazil
title Risks of Adverse Outcomes for Hospitalized COVID-19 Patients during the Four Waves in Brazil According to SARS-CoV-2 Variants, Age Group, and Vaccine Status
title_full Risks of Adverse Outcomes for Hospitalized COVID-19 Patients during the Four Waves in Brazil According to SARS-CoV-2 Variants, Age Group, and Vaccine Status
title_fullStr Risks of Adverse Outcomes for Hospitalized COVID-19 Patients during the Four Waves in Brazil According to SARS-CoV-2 Variants, Age Group, and Vaccine Status
title_full_unstemmed Risks of Adverse Outcomes for Hospitalized COVID-19 Patients during the Four Waves in Brazil According to SARS-CoV-2 Variants, Age Group, and Vaccine Status
title_short Risks of Adverse Outcomes for Hospitalized COVID-19 Patients during the Four Waves in Brazil According to SARS-CoV-2 Variants, Age Group, and Vaccine Status
title_sort risks of adverse outcomes for hospitalized covid 19 patients during the four waves in brazil according to sars cov 2 variants age group and vaccine status
topic COVID-19
SARS-CoV-2
variants of concern
waves
adverse outcomes
Brazil
url https://www.mdpi.com/1999-4915/15/10/1997
work_keys_str_mv AT nataliasatchikohojosouza risksofadverseoutcomesforhospitalizedcovid19patientsduringthefourwavesinbrazilaccordingtosarscov2variantsagegroupandvaccinestatus
AT waasilajassat risksofadverseoutcomesforhospitalizedcovid19patientsduringthefourwavesinbrazilaccordingtosarscov2variantsagegroupandvaccinestatus
AT danielludovicoguidoni risksofadverseoutcomesforhospitalizedcovid19patientsduringthefourwavesinbrazilaccordingtosarscov2variantsagegroupandvaccinestatus
AT fernandasumikahojodesouza risksofadverseoutcomesforhospitalizedcovid19patientsduringthefourwavesinbrazilaccordingtosarscov2variantsagegroupandvaccinestatus